Maarten L. Zandvliet

Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection

Maarten L. Zandvliet, J.H. Frederik Falkenburg, Ellis van Liempt et al. · Haematologica · 2010 · 70 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

Marlies E. J. Reinders, Geertje J. Dreyer, Jonna R. Bank et al. · Journal of Translational Medicine · 2015 · 67 citations · Full text

Medicine, Immunology, Nephrology +16

Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines

Pauline Meij, Inge Jedema, Maarten L. Zandvliet et al. · Journal of Immunotherapy · 2012 · 53 citations

Life Sciences, Immunology, Infectious Diseases +15

TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients

Gijs G. Zom, Marij J.P. Welters, Nikki M. Loof et al. · Oncotarget · 2016 · 50 citations · Full text

Life Sciences, Immunology, Oncology +17

Clinical development of gene- and cell-based therapies: overview of the European landscape

Sofieke de Wilde, Henk‐Jan Guchelaar, Maarten L. Zandvliet et al. · Molecular Therapy — Methods & Clinical Development · 2016 · 42 citations · Full text

Medicine, Biotechnology, Translational Sciences +17